Emira Ayroldi
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Biological Psychiatry top 2%
Papers in
- Immunology 49
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 20
- Immune Response and Inflammation 18
- Immunotherapy and Immune Responses 17
-
- Cell death mechanisms and regulation 8
- Co-authors
- Carlo Riccardi (48 shared papers)Lorenza Cannarile (31 shared papers)Ornella Zollo (10 shared papers)Graziella Migliorati (20 shared papers)Stefano Bruscoli (10 shared papers)Ursula Grohmann (12 shared papers)Domenico Vittorio Delfino (27 shared papers)Roberta Bianchi (9 shared papers)
- Journals
- Blood (9 papers)The Journal of Immunology (4 papers)The FASEB Journal (4 papers)Journal of Chemotherapy (3 papers)Current Pharmaceutical Design (3 papers)
- Partner nations
- ItalyVietnamUnited States
In The Last Decade
Emira Ayroldi
71 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 112
- Immunology 2.1k
- Biological Psychiatry 169
- Behavioral Neuroscience 212
- Cancer Research 378
- Oncology 680
Countries citing papers authored by Emira Ayroldi
This map shows the geographic impact of Emira Ayroldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emira Ayroldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emira Ayroldi more than expected).
Fields of papers citing papers by Emira Ayroldi
This network shows the impact of papers produced by Emira Ayroldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emira Ayroldi. The network helps show where Emira Ayroldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Emira Ayroldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 373 | |
| 2 | 2004 | 297 | |
| 3 | 2009 | 274 | |
| 4 | 2001 | 261 | |
| 5 | 2007 | 260 | |
| 6 | 1998 | 237 | |
| 7 | 2002 | 144 | |
| 8 | 2012 | 140 | |
| 9 | 2007 | 133 | |
| 10 | 1997 | 105 | |
| 11 | 2005 | 86 | |
| 12 | 1995 | 80 | |
| 13 | 2005 | 75 | |
| 14 | 1998 | 70 | |
| 15 | 2006 | 67 | |
| 16 | 2014 | 66 | |
| 17 | 1996 | 59 | |
| 18 | IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo. | 1999 | 50 |
| 19 | 1997 | 48 | |
| 20 | 1999 | 47 |
About Emira Ayroldi
Emira Ayroldi is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 73 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (20 papers), Immune Response and Inflammation (18 papers), Immunotherapy and Immune Responses (17 papers), Cytokine Signaling Pathways and Interactions (9 papers), NF-κB Signaling Pathways (9 papers), Cell death mechanisms and regulation (8 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Immunology (2.1k citations), Biological Psychiatry (169 citations), Behavioral Neuroscience (212 citations), Cancer Research (378 citations) and Oncology (680 citations). Emira Ayroldi has collaborated with scholars based in Italy, Vietnam and United States. Frequent co-authors include Carlo Riccardi, Lorenza Cannarile, Ornella Zollo, Graziella Migliorati, Stefano Bruscoli, Ursula Grohmann, Domenico Vittorio Delfino, Roberta Bianchi, Paolo Puccetti and Maria Laura Belladonna. Their work appears in journals such as Blood, The Journal of Immunology, The FASEB Journal, Journal of Chemotherapy and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.